– Health experts say the COVID-19 omicron variant surge is still weeks away from peaking– and that’s creating a huge demand for everything from testing kits to over-the-counter medicines to help manage the symptoms.
Dr. Casanova serves on the Texas Medical Association COVID-19 Task Force. He says omicron’s rapid spread is impacting every aspect of the healthcare system, from access to over-the-counter medications to monoclonal antibody treatments. So he continues to encourage the vaccine and safety precautions to limit the severity of infections. Yes, and even home remedies won’t hurt if nothing else is handy.
People waking up, know common cold meds can fix it.
Flu season plus mass hysteria equals...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Medicare plans to pay for controversial Alzheimer’s drug, if patients enroll in trialsMedicare plans to provide insurance coverage for Aduhelm, a controversial Alzheimer’s treatment from drugmaker Biogen.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Haymarket drug treatment center files lawsuit against Itasca, claiming rejection of rehab facility was discriminatoryHaymarket has filed a lawsuit after last year's unanimous vote by the Itasca Village Board against allowing a substance-use rehab center to open there.
Source: chicagotribune - 🏆 8. / 91 Read more »
U.S. authorities crack down on crypto ATMs reportedly involved in human and drug traffickingDue to their apparent connection with illicit human and drug trafficking, cryptocurrency ATMs, which were installed at an unprecedented pace... Continue reading
Source: CryptoPanicCom - 🏆 563. / 51 Read more »
Medicare limits coverage of $28,000-a-year Alzheimer’s drugThe initial determination means that patients taking Biogen’s Aduhelm medication will have to be part of research efforts to assess the drug’s effectiveness in slowing the progression of dementia.
Source: AKNewsNow - 🏆 460. / 53 Read more »
Medicare limits coverage of Alzheimer’s drug with $28,000-a-year price tagBiogen’s initial launch price of $56,000 a year for Aduhelm led to an increase of nearly $22 in Medicare’s monthly “Part B” premium for outpatient care, the largest ever in dollar terms but not percentage-wise.
Source: PennLive - 🏆 463. / 53 Read more »
Medicare proposes coverage limits for Alzheimer’s drug AduhelmMounting premium pressures contributed to the determination.
Source: KIRO7Seattle - 🏆 271. / 63 Read more »